Lv J.-C.,Zhang L.-X. .2019 .Prevalence and disease burden of chronic kidney disease. ” Advances in Experimental Medicine and Biology, (2) : 1-15.
Awad S.M. “ .2011 .Chronic renal failure in Al-Anbar, Iraq. Saudi Journal of Kidney Diseases and Transplantation, 22 : 1280-1284.
Saadi F.,Saeed F. .2024 .Risk factors of chronic kidney injury among diabetic and non-diabetic haemodialysis patients in Duhok governorate. Kurdistan region of Iraq.” Duhok Medical Journal, 18(2) : 76-84.
Al-Atbee M.Y.N. .2025 .Spectrum of infectious complications in continuous ambulatory peritoneal dialysis and the role of metabolic derangement to infections. Clinical Nephrology, 104 : 13-22.
Noori E. .2021 .Spectrum of complications of patients with chronic kidney disease on maintenance continuous ambulatory peritoneal dialysis: An experience of tertiary nephrology centre in Najaf City. Open Access Macedonian Journal of Medical Sciences, 7274(2021) : 1529-1534.
Bagdade J.D. . .Disorders of glucose metabolism in uraemia.” Advances in Nephrology from the Necker Hospital. , 8(1979) : 87-100.
Fortes P.C. .2009 .Insulin resistance and glucose homeostasis in peritoneal dialysis. , 29 : 145-148.
Alvestrand A. .1989 .Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. ” Clinical Nephrology, 31 : 175-183.
Koppe L. .2018 .Metabolic abnormalities in diabetes and kidney disease: Role of uremic toxins. ” Current Diabetes Reports, : .
Pecoits-Filho R. . .Interactions between kidney disease and diabetes: dangerous liaisons. ” Diabetology & Metabolic Syndrome, 8(2016) : 50.
Bello A.K. .2017 .Complications of chronic kidney disease: current state, knowledge gaps and strategy for action. ” Kidney International Supplements, 07(2017) : 122-129.
Evans M. .2022 .A narrative review of chronic kidney disease in clinical practice: Current challenges and future perspectives. ” Advances in Therapy, 39 : 33-43.
Abdulhamza S.R.,Alkhattat H.A.H. .2025 .Comparative analysis of inflammatory and biochemical markers in dialysis patients: The impact of age and sex. International Journal of Medical Science and Dental Health, 11 : 36-40.
Swartling O. .2022 .Sex differences in the recognition, monitoring and management of CKD in health care: An observational cohort study. ” Journal of the American Society of Nephrology, 33 : 1903-1914.
Pena M.J. .2017 .Strategies to improve monitoring disease progression, assessing cardiovascular risk and defining prognostic biomarkers in chronic kidney disease. ” Kidney International Supplements, 07(2017) : 107-113.
Gagnebin Y. .2018 .Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage. ” Journal of Pharmaceutical and Biomedical Analysis, 08 : 313-325.
Ju W. .2012 .Genomic biomarkers for chronic kidney disease. ” Translational Research, 01 : 290-302.
Azab A.E.,A.B.M. Alshoukry A.E. .2023 .Prevalence of anaemia and variations of haematological parameters among anemic haemodialysis patients in the Tripoli Region. Trends Journal of Scientific Research, 611(2023) : 46-63.
Mazhar R. . .Prevalence of anemia in end stage renal disease patients on maintenance haemodialysis. Pakistan Journal of Health Sciences, 4(2023) : 860-133.
Madore F. . .Anemia in haemodialysis patients. ” Journal of the American Society of Nephrology, 8(1997) : 1921-1929.
Abdulrahaman Y. . .Packed cell volume, reticulocyte count and index among patients with chronic kidney disease in Sokoto, North Western. -12-801238-3, (2013) : 64899-7.
Ratnani A.P. .2022 .A study on the management of anaemia in chronic kidney disease. International Journal of Research in Ayurveda and Pharmacy, 13 : 130354-4343.
Al-Jabi S.W. .2023 .A multicentre descriptive analysis of anemia management in haemodialysis patients and its association with quality of life. ” BMC Nephrology, 24 : 197.
Valderrábano F. .2003 .PRE-dialysis survey on anaemia management. ” Nephrology Dialysis Transplantation, : .
Szeto .2007 .New-onset hyperglycaemia in nondiabetic Chinese patients started on peritoneal dialysis. American Journal of Kidney Diseases, 01 : 524-532.
Abe M.,Kalantar-Zadeh K. .2015 .“Haemodialysis-induced hypoglycaemia and glycaemic disarrays. ” Nature Reviews Nephrology, 38 : 302-313.
Henderson W.R. . .Hyperglycaemia in acutely ill emergency patients-Cause or effect?”. Canadian Journal of Emergency Medicine, 8(2006) : 339-343.
Jin Y. .2014 .Blood glucose fluctuations in haemodialysis patients with end-stage diabetic nephropathy. ” Journal of Diabetes and Its Complications, 12 : 395-399.
Lombardi G. .2024 .Sex differences in chronic kidney diseaserelated complications and mortality across levels of glomerular filtration rate. ” Nephrology Dialysis Transplantation, 39 : 2005-2015.
Ricardo A.C. .2019 .Sex-related disparities in CKD progression. ” Journal of the American Society of Nephrology, 30 : 137-146.
Liang Y. .2022 .Clinical characteristics and management of haemodialysis patients with pre-dialysis hypertension: a multicentre observational study. ” Renal Failure, 2136527 : 1821-1828.
Assimon M.M. .2016 .Ultrafiltration rate and mortality in maintenance haemodialysis patients. American Journal of Kidney Diseases, 06 : 911-922.
Flythe J.E. .2010 .Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. , 383 : 250-257.
Rodriguez V.O. .1995 .Hypoglycaemia in dialysis patients. , 8(1995) : 1525-139X.
Haji S. . .An analysis of anaemia and serum calcium levels in chronic kidney disease as an indicator of severity and progression of disease in patients of South Punjab, Pakistan. ” Journal of Health and Rehabilitation Research, 4(2024) : 1261-9.
Sayed Abo,M. Abo .1888 .Relationship between anaemia and biochemical parameters of mineral bone disorders in chronic kidney disease patients. International Medical Journal, 130263 : 0-0.
Dincer M.T. .2022 .To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3-5 nondialysis patients?” Clinical Nephrology. , 98 : 239-246.
Torregrosa J.-V.,Recomendaciones de la Sociedad J.-V. .2022 .Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM). ” Nefrología, 03 : 1-37.
Shastry S.,Belurkar S. .2019 .The spectrum of red blood cell parameters in chronic kidney disease: A study of 300 cases. Journal of Applied Hematology, 13 : 19.